Tigecycline, a broad-spectrum antibiotic, has seen the entry of generic versions into the market. These generics are becoming more widely available in pharmacies, offering a potentially more affordable option for patients. The availability of tigecycline generics can be attributed to the expiration of patents, as indicated by Drug Patent Watch [1]. The introduction of generics into the market is a common occurrence once patents expire, leading to increased accessibility and affordability of medications for patients [2]. Additionally, a study published on the National Center for Biotechnology Information website highlighted the importance of generic drugs in improving access to essential medications [3]. Overall, the availability of tigecycline generics in pharmacies is expected to increase, providing patients with more options for their antibiotic therapy needs.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/TIGECYCLINE
[2] https://www.uspharmacist.com/article/new-generics-in-the-pipeline
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575121/